Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 228 Neoplasm Metastasis 19 Neoplasms 9 Breast Neoplasms, Male 7 Breast Diseases 7 Ovarian Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 4 Recurrence 3 Obesity 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Carcinoma In Situ 3 Breast Cancer Metastatic 3 Advanced Breast Cancer 3 Prostatic Neoplasms 2 Neoplasms by Site 2 Multiple Endocrine Neoplasia Type 1 2 Carcinoma, Renal Cell 2 Bulbo-Spinal Atrophy, X-Linked 2 Arthralgia 2 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Wake Disorders 1 Skin Diseases 1 Sexuality 1

Interventions

Exercise 35 Therapeutics 30 Modafinil 21 Yoga 17 Surveys and Questionnaires 16 Methylphenidate 16 Psychiatric Rehabilitation 14 Acupuncture Therapy 11 Educational Status 9 Walking 8 Early Intervention, Educational 8 Cognitive Behavioral Therapy 8 Ultraviolet Therapy 7 Control Groups 7 Therapeutic Touch 6 Physical Therapy Modalities 6 Mental Status and Dementia Tests 6 Exercise Therapy 6 Acceptance and Commitment Therapy 6 Sugars 5 Qigong 5 Palliative Care 5 Counseling 5 Standard of Care 4 Saline Solution 4 Methods 4 Epoetin Alfa 4 Dexamethasone 4 Behavior Therapy 4 Acupressure 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Fatigue × exemestane × Clear all

NCT00659373 2016-07-25

Co-SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed

86 enrolled 4 charts

Breast Neoplasms, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡